Difference between revisions of "Team:Cornell/overview"

 
(41 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
{{:Team:Cornell/header}}
 
{{:Team:Cornell/header}}
 
<html>
 
<html>
    <body style="background-color:#455a64">
+
<head>
    <div class="whiteContainer" style="background-color:white; padding = 0 px">
+
<style>
      <div class="container" style = "overflow:hidden">
+
.small-row {
         <h1>whiteContainer</h1>
+
margin-right: 100px;
                 <img src = "https://static.igem.org/mediawiki/2015/f/f7/Cornell_infographicOverview.png" width=100% height = auto align="center" / >
+
margin-left: 100px;
      </div>
+
}
 +
</style>
 +
</head>
 +
<body >
 +
<div class = "container" style="margin-top: 100px;">
 +
    <div class="row">
 +
<div class="col-md-12">
 +
          
 +
                 <img src = "https://static.igem.org/mediawiki/2015/a/aa/Cornell_updatedInfographic.png" style="width: 80%; display: block; margin-right:auto; margin-left: auto;" / >
 +
</div>
 
     </div>
 
     </div>
 +
 
 +
<div class = "row small-row">
 +
<div class="col-md-12">
 +
<h1>Mission Statement</h1>
 +
<p>We at fishPHARM believe sustainable and efficient aquaculture is one of the best ways of providing a growing global population with the food it needs to thrive. The overuse of antibiotics on today’s fish farms is detrimental to both the consumer and the aquaculture industry. Outbreaks of bacterial coldwater disease (BCWD) and lack of efficient preventative monitoring systems are real issues that affect the productivity of fish farmers today. We make it our mission to produce antibiotic-free treatments for BCWD, design and manufacture effective and safe drug delivery methods for aquacultured fish, and design and manufacture farm monitoring systems for the purpose of disease prevention and general fish well-being. With these initiatives, fishPHARM will help aquaculture around the globe attain a more sustainable position for food production.</p>
 +
 +
</div>
 
     </div>
 
     </div>
  
<div class = "whiteContainer" style="background-color:white;overflow:hidden">
+
<div class = "row small-row gray">
    <div class="container">
+
<div class="col-md-12">
 +
<h1>Project Overview</h1>
 +
<p>Cornell University is situated in the heart of the Finger Lakes region of Upstate New York where a diverse array of salmonid fish call home. Unfortunately, the region has been impacted by a series of bacterial coldwater disease (BCWD) outbreaks, severely reducing the number of fish available for recreational fishing and local aquaculture. BCWD is a potentially lethal bacterial infection of salmonid fish species caused by the pathogen <i>Flavobacterium psychrophilum</i>. Fish suffering from BCWD develop skin lesions that effectively renders the fish inedible and unviable. The disease is not only found in Upstate New York, but also has been cited in other fish farms and hatcheries where fish are raised in close quarters. In fact, other American fish farms have reported instances in which over 30-45% of trout raised have been lost due to BCWD [1]. The grave economic and agricultural consequences of BCWD are unresolved by current means of treatment consisting of antibiotics. This year, Cornell iGEM has developed fishPHARM: a comprehensive prevention and treatment plan that uses the tools of synthetic biology to combat BCWD.</p>
  
        <h1>Project Overview</h1>
+
<p>Since the etiology of BCWD is characterized by intra-organismal microbial proliferation, our treatment protocol seeks to reduce microbial loads within the infected fish through the use of a peptide called Entericidin B. Recent studies have shown the peptide to be toxic to the growth of <i>Flavobacterium psychrophilum</i>, thereby providing a potential treatment to BCWD[2]. Hundreds of bacterial entericidin phenotypes exist naturally. This year, Cornell iGEM has engineered 20 strains of <i>Escherichia</i> coli for the regulated production of such peptides to test their efficacy against the growth of <i>Flavobacterium psychrophilum</i>. In doing so, we plan to develop the most effective <a href="https://2015.igem.org/Team:Cornell/wetlab">probiotic treatment</a> for BCWD and advance the study of therapeutic probiotic treatments in combatting similar diseases.</p>
  
        <p class="lead"><p>Cornell University is situated in the heart of the Finger Lakes region of Upstate New York State where a diverse array of salmonid fish call home. Unfortunately, the region has also been impacted by a series of bacterial coldwater disease (BCWD) outbreaks, severely reducing the number of fish available for recreational fishing and local aquaculture. BCWD is a potentially lethal bacterial infection of salmonid fish species caused by the pathogen <i>Flavobacterium psychrophilum</i>. Fish suffering from BCWD develop skin lesions that effectively renders the fish inedible and unviable. The disease is not only found in Upstate New York, but also has been cited in other fish farms and hatcheries where fish are raised in close quarters. In fact, other American fish farms have reported instances in which over over 30-45% of trout raised have been lost due to BCWD [1]. The grave economic and agricultural consequences of BCWD are unresolved by current means of treatment consisting of antibiotics. This year, Cornell iGEM has developed fishPHARM: a comprehensive prevention and treatment plan that uses the tools of synthetic biology to combat BCWD.</p>
+
<p>In addition, the team engineered a novel <a href="https://2015.igem.org/Team:Cornell/Design">fish drug delivery system</a> to safely administer our probiotic treatment without environmental harm. We have developed a working prototype of a fish tag that can safely latch onto the skin of a fish and demonstrate the secure and time-effective release of our peptide to treat BCWD in an infected fish. Our fish tag aligns with current practices of fish tagging in the aquaculture industry today, and has immediate potential to be implemented on both a local and global scale. We have shared the device with <a href="https://2015.igem.org/Team:Cornell/Practices">local hatcheries and fish farms</a> to both garner feedback to improve prototype designs as well as help local farmers combat coldwater disease. </p>
  
<p>Since the etiology of BCWD is characterized by intra-organismal microbial proliferation our treatment protocol seeks to reduce microbial loads within the infected fish through the use of a peptide called Entericidin B. Recent studies have shown the peptide to be toxic to the growth of F. psychrophilum, thereby providing a potential treatment to BCWD[2]. Hundreds of bacterial entericidin phenotypes exist naturally. This year, Cornell iGEM has engineered over 20 strains of Escherichia coli for the regulated production of such peptides to test their efficacy against the growth of F. psychrophilum. In doing so, we plan to develop the most effective probiotic treatment for BCWD and advance the study of therapeutic probiotic treatments in combatting similar diseases.</p>
+
<p>Success of this putative microbial control system holds important ramifications for human and animal health, as similar treatment methods could be devised for other bacterial infections. Prevention of BCWD will help provide a more secure, sustainable future in the fish industry and beyond to aid growing population necessary to sustain the continued increase of the human population.</p>
 +
</div>
 +
    </div>
 +
    <div class = "row small-row">
 +
<div class="col-md-12">
 +
<h1>Project Background</h1>
 +
<p><b>The Disease</b>: Bacterial coldwater disease (BCWD) is a bacterial infection among fish caused by <i>Flavobacterium psychrophilum</i>, a Gram-negative bacillus. The name of the disease is derived from the fact that infection typically occurs at temperatures below 13 degrees Celsius [4]. The rapid spread of this waterborne disease occurs through horizontal transmission of bacteria from one fish to another, and is exacerbated when fish are contained in dense populations such as those commonly found on fish farms [5]. Symptoms of BCWD include external fish skin lesions and necrosis of the fins, both of which render fish commercially inviable [4]. </p>
  
<p>In addition, the team plans to engineer a novel fish drug delivery system to safely administer our probiotic treatment without environmental harm. We have developed a working prototype of a fish tag that can safely latch onto the skin of a fish and demonstrate the secure and time-effective release of our peptide to treat BCWD in an infected fish. Our fish tag aligns with current practices of fish tagging in the aquaculture industry today, and has immediate potential to be implemented on both a local and global scale. We have shared the device with local hatcheries and fish farms to both garner feedback to improve prototype designs as well as help local farmers combat coldwater disease. </p>
+
<p><b>Local BCWD Outbreaks</b>: Cornell University is situated in the Finger Lakes region as well as a part of the Great Lakes region. Unfortunately, the region has recently been hard hit by the effects of BCWD. For example, in 2010, Wolf Lake State Fish Hatchery, a Ohio facility associated with Lake Erie, reported an outbreak of BCWD among its stock of steelhead. Mortality rates among its 285,000-fish population rapidly reached 100 individual salmonids per day. By the time antibiotics were administered, mortalities had peaked at 371 fish a day [3]. Rampant BCWD infections in our local area has inspired us to create fishPHARM to help prevent local infections from spreading. </p>
 
+
<p>Success of this putative microbial control system holds important ramifications for human and animal health, as similar treatment methods could be devised for bacterial infections among humans. Prevention of BCWD will help provide a more secure, sustainable future in the fish industry and beyond to aid growing population necessary to sustain the continued increase of the human population.</p>
+
  
 +
<p><b>Aquaculture and Fish Farming</b>: Outbreaks of BCWD are very common, observed globally, and can result in harsh economic effects on commercial salmonid producers [4]. Wild salmonid populations are also susceptible and wild fish can easily contract the disease via contact with domestic populations . At principal risk are farms in the United States that grow salmonids in cramped conditions. Aquacultural production of salmonids is one of the the fastest growing and largest food markets globally, producing hundreds of millions of tons of fish and representing a market worth hundreds of billions of dollars. Fish farming has been a rapid response to the growing crisis of global overfishing. In addition to ensuring that hungry populations have access to a cheap yet nutritious source of protein, aquaculture provides fishermen with a means of compensating for the shrinkage of wild fish populations. Heavily populated countries such as Norway, Chile and Japan are leading consumers of aquacultural products, and rely on farm-grown fish to help feed the masses. Epidemics among fish farms could thus have disastrous consequences. The aim of our project is not only to prevent economic harm to the fishermen, but to aid communities with economies heavily dependent on the aquaculture industry and provide food security as well. </p>
  
 +
<p><b>Threat to Wildlife</b>: BCWD is not only a threat to the commercial fish farming industry, but also a concern to the ecology of the wild salmonid fish population. When these fish farms are located in larger bodies of water, the pathogen <i>F. psychrophilum </i> can escape natural or man-made boundaries to infect wild fish populations [4]. Compounding to this problem is the fact that juvenile fish, which are more susceptible to infection, are commonly found in estuaries and bays where the fish farms are usually placed. Since salmon are a crucial source of nutrition for a plethora of secondary and tertiary consumers (bears, otters and ospreys, for instance), mass die-offs among the fish could devastate local ecosystems [5]. Containing <i>F. psychrophilum</i> is thus crucial to both the economic and ecological well-being of the earth's natural habitat. </p>
  
 +
<p><b>Current Solutions</b>: The current treatment protocols for BCWD involve chemotherapeutic agents. Broad-spectrum antibiotics such as oxytetracycline are currently being used  by fish farms to treat BCWD [4], but these antibiotics remain in the food we consume, leach into the ocean or soil surrounding farms, and give bacteria the opportunity to develop resistance. Antibiotic resistance reduces the effectiveness of the administered antibiotic in successive generations, thereby worsening the effects of BCWD over time. This prompts the need for a treatment for BCWD that is less prone to resistance than antibiotics.</p>
 +
</div>
 
     </div>
 
     </div>
    </div>
+
<div class = "row small-row gray">
<!-- /.container -->
+
<div class="col-md-12">
    <div class = "whiteContainer" style="background-color: #e8e7e7; overflow:hidden">
+
<h1 id="refs">References </h1>
    <div class="container">
+
<p> [1]Ryce, E., & Zale, A. (2004). Bacterial Coldwater Disease in Westslope Cutthroat Trout: Hatchery Epidemiology and Control. Retrieved from the Wild Fish Habitat Initiative Website: http://wildfish.montana.edu/docs/BCWD_FinalReportJune2004.pdf</p>  
 
+
        <h1>Project Background</h1>
+
 
+
        <p class="lead">Use this document as a way to quickly start any new project.<br> All you get is this text and a mostly barebones HTML document.</p>
+
 
+
    </div>
+
    </div>
+
<!-- /.container -->
+
    <div class = "whiteContainer" style="background-color: white; overflow:hidden">
+
 
+
    <div class="container">
+
        <h1>Safety</h1>
+
 
+
        <p>Cornell iGEM understands the inherent risks of working in a lab facility and aims to take all necessary precautions to ensure no personal or environmental harm occurs. To this end, we have implemented the following safety procedures below. Our completed safety form can be found here. </p>
+
 
+
<p><font size="4"><b>Specific Safety Concerns</p></font></b>
+
 
+
<p><b>Laboratory Safety</b>: Our project involves regular use of ethidium bromide, a DNA-intercalating agent known to cause cancer, as well as the use of powerful UV light, for visualization of gel electrophoresis. We must prepare culture media with antibiotics, which could be harmful to humans in large doses. We also work with ethanol lamps to maintain a sterile environment, which do involve having an open flame on the benchtop. </p>
+
 
+
<p><b>Environmental Safety</b>: If any biological materials escape from the lab there is a risk of transfer of antibiotic resistance from our engineered strains into other organisms. Furthermore, dissemination of the Entericidin B peptide could potentially affect the microbiological ecosystem present at the release point, but we plan to secure the release of the EcnB peptide through the use of our engineered fish tag system. </p>
+
 
+
 
+
<p><b>Flavobacterium</b>: <i>Flavobacterium psychrophilum</i>, while a dangerous pathogen for salmonids, carries little to no negative health consequences for humans. It has been classified as a Biosafety Level 1 organism according to the NIH, and is thus essentially harmless to the human population. It is safe to work with and does not require special laboratory protocols beyond those used to work with E. coli. </p>
+
 
+
 
+
 
+
<p><b>Entercidin B</b>: Entericidin B is a bacteriolytic and thus is toxic to bacterial cells. The peptide has been found in the human gut, indicating that it is not of harm to the human body at the dosages used in the product. Working with EcnB is thus a relatively risk-free endeavor and does not require special safety procedures. </p>
+
 
+
 
+
<p><b><font size="4">Safety Protocol</font><p></b>
+
 
+
<p><b>Wet Lab</b>: All lab members wear nitrile gloves, closed-toe shoes, and use eye protection when working with volatile chemicals or UV light. Gloves are replaced and hands are washed immediately after using ethidium bromide or any of the metal solutions. Members work in small groups to ensure if any harm comes to one, others are there to assist. When working with a new reagent or piece of equipment, a faculty lab manager or experienced member is always present to assist. </p>
+
 
+
 
+
<p>There are taped off, designated areas for working with ethidium bromide. These areas are cleaned before and after work and are the only areas the solution may touch. All toxic waste is placed in a specialized receptacle and is picked up and disposed of by Cornell Environmental Health and Safety. </p>
+
 
+
 
+
<p>All disposables that come in contact with biologics are disposed of in biohazard waste. The lab space also contains sharps containers for disposal of all sharps that contact biological material. All biohazard waste is autoclaved and transported to the building's centralized waste facility where it is disposed of as regulated biological waste. </p>
+
 
+
<p>We maintain 2 copies of MSDS's for every chemical we use in the lab: one for our own records and one for the lab manager and users of the lab space who are not part of our team. The lab is equipped with flame-retardant benches, spill kits, safety showers, eye-washes, and fire extinguishers. </p>
+
 
+
<p><b>Dry Lab</b>: We use the Emerson Machine Shop for fabrication; each of the dry lab subteam members has attended the prescribed training session for use of the shop and has learned to use each of the tools safely. Each member of the dry lab subteam was trained in the safe usage of the milling machine and the metal lathe. </p>
+
 
+
 
+
<p>All machine shop work is conducted under the supervision of the Emerson machine shop staff. Safety goggles were worn at all times. Masks and gloves are worn as appropriate. Closed-toe shoes and long pants were also worn when working in the machine shop. While working in the machine shop we maintained a clean work environment so we could maintain visibility at all times. When lifting heavy objects, proper lifting technique was used, and an appropriate number of individuals were used for lifting said objects.</p>
+
 
+
<p><b><font size="4">Training and Enforcement </font></b> <p>
+
 
+
<p><b>Training </b>: All team members who work in the wet lab must complete Cornell EH&amp;S general lab safety and chemical waste disposal courses prior to the onset of work. These courses set specific guidelines and are the standard requirement for work in a biosafety-level 1 lab at Cornell. Additionally, all team members must complete a lab orientation session with the manager of the BME instructional lab, Dr. Shivaun Archer. During these sessions, Dr. Archer familiarizes new members with the safety equipment and procedures specific to the labspace in which we work. </p>
+
 
+
<p>Prior to the onset of work for the year, all new members are required to go through a safety training program. During this program, safety officers reinforce safety procedures learned during the EH&amp;S courses, discuss safety protocol pertaining to specific chemicals with which we work, and ensure all lab members fully understand all safety procedures. </p>
+
 
+
 
+
 
+
<p><b>Safety Officers</b>: The safety officers were chosen to be team members who could directly supervise the activities of the other team members. One team member each was chosen for the wet and dry lab subteams to ensure that all team members are working safely, whether with bacterial cultures or power tools. These team members also act as liaisons to the wet lab and machine shop managers and, when necessary, the <a href="http://www.ibc.cornell.edu/" >Institutional Biosafety Committee </a>to ensure proper equipment usage. </p>
+
 
+
<p>These team members are responsible for discussing the proposed work plan for the project with the wet lab and machine shop managers before starting work to ensure that it is safe to continue. In the case of the wet lab in particular, this involves going through a detailed list of protocols, including all organisms, chemicals, and genetic constructs being worked with, to ensure conformity with the <a href="http://sp.ehs.cornell.edu/lab-research-safety/bios/biological-safety-manuals/Pages/default.aspx" >Environmental Health &amp; Safety guidelines</a>. They must go through the same safety training as all other team members, but are required to redo the training each time we recruit new members in order to keep up-to-date with safety considerations. In addition, they maintain contact with the supervisors of the workspaces, usually in the form of a weekly check-in, to discuss any safety concerns that have arisen and ensure that equipment continues to be used properly. </p>
+
 
+
 
+
<p><b>Enforcement</b>: Team members who violate safety rules are required to work under the supervision of the safety officers for the remainder of the week, or until the safety officer believes the member is capable of performing the task unsupervised. For multiple infractions or complete disregard to safety protocols, a member may be restricted from laboratory work until he/she undergoes EHS chemical safety online training again, and demonstrates proper performance to a team leader of failed technique(s) in a controlled setting.</p>
+
 
+
 
+
 
+
</p>
+
<div class="container" style = "overflow:hidden; background-color: #e8e7e7;">
+
<h1 id="refs">References </h1>
+
                                                <p> [1]Ryce, E., & Zale, A. (2004). Bacterial Coldwater Disease in Westslope Cutthroat Trout: Hatchery Epidemiology and Control. Retrieved from the Wild Fish Habitat Initiative Website: http://wildfish.montana.edu/docs/BCWD_FinalReportJune2004.pdf</p>  
+
 
<p>[2]Schubiger, C., Orfe, L., Sudheesh, P., Cain, K., Shah, D., & Call, D. (2014). Entericidin Is Required for a Probiotic Treatment (Enterobacter sp. Strain C6-6) To Protect Trout from Cold-Water Disease Challenge.Applied and Environmental Microbiology Appl. Environ. Microbiol.,81(2), 658-665. </p>
 
<p>[2]Schubiger, C., Orfe, L., Sudheesh, P., Cain, K., Shah, D., & Call, D. (2014). Entericidin Is Required for a Probiotic Treatment (Enterobacter sp. Strain C6-6) To Protect Trout from Cold-Water Disease Challenge.Applied and Environmental Microbiology Appl. Environ. Microbiol.,81(2), 658-665. </p>
 +
<p>[3] http://www.glfc.org/boardcomm/fhealth/2010annualreport.pdf</p>
 +
<p>[4] Starliper, Clifford. "Bacterial Coldwater Disease of Fishes Caused by Flavobacterium Psychrophilum." Bacterial Coldwater Disease of Fishes Caused by Flavobacterium Psychrophilum. Journal of Advanced Research, n.d. Web. 14 Sept. 2015.</p>
 +
<p>[5] LaFrentz, B., & Cain, K. (n.d.). Bacterial Coldwater Disease. Retrieved September 15, 2015.</p>
 
 
</div>
 
 
<br><br>
 
</div>
 
    </div>
 
    </div>
 
    <!-- /.container -->
 
 
 
    <!-- footer-->
 
 
<div class="whiteContainer" style="background-color: #455a64; box-sizing: border-box; overflow:hidden">
 
<div class="col-md-8" style="margin-left:150px">
 
</a><a href="https://2015.igem.org/Team:Cornell"><img src="https://static.igem.org/mediawiki/2015/2/27/Cornell_logo.png" width=auto height="60"></a>
 
</div>
 
 
<div class="col-md-2" style="margin-top: 30 px">
 
                        <div class = "container">
 
                              <h2.small style="font-size:14px; color: white"><br> B07 Weill Hall, Ithaca, NY</h>
 
</div>
 
                        <div class = "container">
 
      <a href="https://www.facebook.com/cornelligem"><img src="https://static.igem.org/mediawiki/2015/6/63/Cornell_fb.png" width=auto height="30"></a>
 
      <a href="https://twitter.com/cugem"><img src="https://static.igem.org/mediawiki/2015/0/04/Cornell_twitter.png" width=auto height="30"></a>
 
      <a href="mailto:cornelligem@gmail.com?m"><img src="https://static.igem.org/mediawiki/2015/5/5d/Cornell_email.png" width=auto height="30"></a>
 
                          </div>
 
 
 
</div>
 
</div>
</div>
+
</div>
    </body>
+
<br><br>
 +
</div>
 +
</body>
 
</html>
 
</html>
 +
{{:Team:Cornell/footer}}

Latest revision as of 03:32, 19 September 2015

Cornell iGEM

shopify analytics ecommerce
tracking

Mission Statement

We at fishPHARM believe sustainable and efficient aquaculture is one of the best ways of providing a growing global population with the food it needs to thrive. The overuse of antibiotics on today’s fish farms is detrimental to both the consumer and the aquaculture industry. Outbreaks of bacterial coldwater disease (BCWD) and lack of efficient preventative monitoring systems are real issues that affect the productivity of fish farmers today. We make it our mission to produce antibiotic-free treatments for BCWD, design and manufacture effective and safe drug delivery methods for aquacultured fish, and design and manufacture farm monitoring systems for the purpose of disease prevention and general fish well-being. With these initiatives, fishPHARM will help aquaculture around the globe attain a more sustainable position for food production.

Project Overview

Cornell University is situated in the heart of the Finger Lakes region of Upstate New York where a diverse array of salmonid fish call home. Unfortunately, the region has been impacted by a series of bacterial coldwater disease (BCWD) outbreaks, severely reducing the number of fish available for recreational fishing and local aquaculture. BCWD is a potentially lethal bacterial infection of salmonid fish species caused by the pathogen Flavobacterium psychrophilum. Fish suffering from BCWD develop skin lesions that effectively renders the fish inedible and unviable. The disease is not only found in Upstate New York, but also has been cited in other fish farms and hatcheries where fish are raised in close quarters. In fact, other American fish farms have reported instances in which over 30-45% of trout raised have been lost due to BCWD [1]. The grave economic and agricultural consequences of BCWD are unresolved by current means of treatment consisting of antibiotics. This year, Cornell iGEM has developed fishPHARM: a comprehensive prevention and treatment plan that uses the tools of synthetic biology to combat BCWD.

Since the etiology of BCWD is characterized by intra-organismal microbial proliferation, our treatment protocol seeks to reduce microbial loads within the infected fish through the use of a peptide called Entericidin B. Recent studies have shown the peptide to be toxic to the growth of Flavobacterium psychrophilum, thereby providing a potential treatment to BCWD[2]. Hundreds of bacterial entericidin phenotypes exist naturally. This year, Cornell iGEM has engineered 20 strains of Escherichia coli for the regulated production of such peptides to test their efficacy against the growth of Flavobacterium psychrophilum. In doing so, we plan to develop the most effective probiotic treatment for BCWD and advance the study of therapeutic probiotic treatments in combatting similar diseases.

In addition, the team engineered a novel fish drug delivery system to safely administer our probiotic treatment without environmental harm. We have developed a working prototype of a fish tag that can safely latch onto the skin of a fish and demonstrate the secure and time-effective release of our peptide to treat BCWD in an infected fish. Our fish tag aligns with current practices of fish tagging in the aquaculture industry today, and has immediate potential to be implemented on both a local and global scale. We have shared the device with local hatcheries and fish farms to both garner feedback to improve prototype designs as well as help local farmers combat coldwater disease.

Success of this putative microbial control system holds important ramifications for human and animal health, as similar treatment methods could be devised for other bacterial infections. Prevention of BCWD will help provide a more secure, sustainable future in the fish industry and beyond to aid growing population necessary to sustain the continued increase of the human population.

Project Background

The Disease: Bacterial coldwater disease (BCWD) is a bacterial infection among fish caused by Flavobacterium psychrophilum, a Gram-negative bacillus. The name of the disease is derived from the fact that infection typically occurs at temperatures below 13 degrees Celsius [4]. The rapid spread of this waterborne disease occurs through horizontal transmission of bacteria from one fish to another, and is exacerbated when fish are contained in dense populations such as those commonly found on fish farms [5]. Symptoms of BCWD include external fish skin lesions and necrosis of the fins, both of which render fish commercially inviable [4].

Local BCWD Outbreaks: Cornell University is situated in the Finger Lakes region as well as a part of the Great Lakes region. Unfortunately, the region has recently been hard hit by the effects of BCWD. For example, in 2010, Wolf Lake State Fish Hatchery, a Ohio facility associated with Lake Erie, reported an outbreak of BCWD among its stock of steelhead. Mortality rates among its 285,000-fish population rapidly reached 100 individual salmonids per day. By the time antibiotics were administered, mortalities had peaked at 371 fish a day [3]. Rampant BCWD infections in our local area has inspired us to create fishPHARM to help prevent local infections from spreading.

Aquaculture and Fish Farming: Outbreaks of BCWD are very common, observed globally, and can result in harsh economic effects on commercial salmonid producers [4]. Wild salmonid populations are also susceptible and wild fish can easily contract the disease via contact with domestic populations . At principal risk are farms in the United States that grow salmonids in cramped conditions. Aquacultural production of salmonids is one of the the fastest growing and largest food markets globally, producing hundreds of millions of tons of fish and representing a market worth hundreds of billions of dollars. Fish farming has been a rapid response to the growing crisis of global overfishing. In addition to ensuring that hungry populations have access to a cheap yet nutritious source of protein, aquaculture provides fishermen with a means of compensating for the shrinkage of wild fish populations. Heavily populated countries such as Norway, Chile and Japan are leading consumers of aquacultural products, and rely on farm-grown fish to help feed the masses. Epidemics among fish farms could thus have disastrous consequences. The aim of our project is not only to prevent economic harm to the fishermen, but to aid communities with economies heavily dependent on the aquaculture industry and provide food security as well.

Threat to Wildlife: BCWD is not only a threat to the commercial fish farming industry, but also a concern to the ecology of the wild salmonid fish population. When these fish farms are located in larger bodies of water, the pathogen F. psychrophilum can escape natural or man-made boundaries to infect wild fish populations [4]. Compounding to this problem is the fact that juvenile fish, which are more susceptible to infection, are commonly found in estuaries and bays where the fish farms are usually placed. Since salmon are a crucial source of nutrition for a plethora of secondary and tertiary consumers (bears, otters and ospreys, for instance), mass die-offs among the fish could devastate local ecosystems [5]. Containing F. psychrophilum is thus crucial to both the economic and ecological well-being of the earth's natural habitat.

Current Solutions: The current treatment protocols for BCWD involve chemotherapeutic agents. Broad-spectrum antibiotics such as oxytetracycline are currently being used by fish farms to treat BCWD [4], but these antibiotics remain in the food we consume, leach into the ocean or soil surrounding farms, and give bacteria the opportunity to develop resistance. Antibiotic resistance reduces the effectiveness of the administered antibiotic in successive generations, thereby worsening the effects of BCWD over time. This prompts the need for a treatment for BCWD that is less prone to resistance than antibiotics.

References

[1]Ryce, E., & Zale, A. (2004). Bacterial Coldwater Disease in Westslope Cutthroat Trout: Hatchery Epidemiology and Control. Retrieved from the Wild Fish Habitat Initiative Website: http://wildfish.montana.edu/docs/BCWD_FinalReportJune2004.pdf

[2]Schubiger, C., Orfe, L., Sudheesh, P., Cain, K., Shah, D., & Call, D. (2014). Entericidin Is Required for a Probiotic Treatment (Enterobacter sp. Strain C6-6) To Protect Trout from Cold-Water Disease Challenge.Applied and Environmental Microbiology Appl. Environ. Microbiol.,81(2), 658-665.

[3] http://www.glfc.org/boardcomm/fhealth/2010annualreport.pdf

[4] Starliper, Clifford. "Bacterial Coldwater Disease of Fishes Caused by Flavobacterium Psychrophilum." Bacterial Coldwater Disease of Fishes Caused by Flavobacterium Psychrophilum. Journal of Advanced Research, n.d. Web. 14 Sept. 2015.

[5] LaFrentz, B., & Cain, K. (n.d.). Bacterial Coldwater Disease. Retrieved September 15, 2015.




B07 Weill Hall, Ithaca, NY